Skip to content
CNS Pulse
PipelineIndicationsCompaniesTargetsReadoutsConferencesAbstractsAuthors
  1. Home
  2. Pipeline
  3. Solanezumab
  4. LY-2062430

Synonym · Biologic

LY-2062430

LY-2062430 is a synonym for Solanezumab, developed by Eli Lilly and Company.

Status
Discontinued for Alzheimer's disease
Mechanism
Amyloid-beta (aggregated) Inhibitor
Developer
Eli Lilly and Company

Programs

  • Solanezumab for Alzheimer's diseaseDiscontinuedDiscontinued

Also known as

  • LY2062430
  • solanezumab
  • 955085-14-0
  • m266 (humanized)

View the full Solanezumab profile →

CNS Pulse

© 2026 CNS Pulse · Psychopharmacology pipeline intelligence & conference reports.

Deal activity · Changelog